Search

Angelica M. Mckinney

Examiner (ID: 19505, Phone: (571)270-3321 , Office: P/2653 )

Most Active Art Unit
2653
Art Unit(s)
2694, 2653
Total Applications
624
Issued Applications
506
Pending Applications
67
Abandoned Applications
76

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 3475640 [patent_doc_number] => 05399346 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-03-21 [patent_title] => 'Gene therapy' [patent_app_type] => 1 [patent_app_number] => 8/220175 [patent_app_country] => US [patent_app_date] => 1994-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 9669 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/399/05399346.pdf [firstpage_image] =>[orig_patent_app_number] => 220175 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/220175
Gene therapy Mar 29, 1994 Issued
08/213668 POLYMERIC GENE DELIVERY SYSTEM Mar 14, 1994 Abandoned
Array ( [id] => 3728878 [patent_doc_number] => 05652223 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-29 [patent_title] => 'DNA encoding CAI resistance proteins and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/212190 [patent_app_country] => US [patent_app_date] => 1994-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 16208 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/652/05652223.pdf [firstpage_image] =>[orig_patent_app_number] => 212190 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/212190
DNA encoding CAI resistance proteins and uses thereof Mar 13, 1994 Issued
08/212394 TARGETED DELIVERY OF GENES ENCODING SERETORY PROTEINS Mar 10, 1994 Abandoned
Array ( [id] => 3610653 [patent_doc_number] => 05589581 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-31 [patent_title] => 'DNA sequences useful for the synthesis of carotenoids' [patent_app_type] => 1 [patent_app_number] => 8/209617 [patent_app_country] => US [patent_app_date] => 1994-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 10529 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/589/05589581.pdf [firstpage_image] =>[orig_patent_app_number] => 209617 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/209617
DNA sequences useful for the synthesis of carotenoids Mar 9, 1994 Issued
Array ( [id] => 3704469 [patent_doc_number] => 05654167 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-05 [patent_title] => 'Antimicrobial proteins, compositions containing same and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/208181 [patent_app_country] => US [patent_app_date] => 1994-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 24 [patent_no_of_words] => 10821 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/654/05654167.pdf [firstpage_image] =>[orig_patent_app_number] => 208181 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/208181
Antimicrobial proteins, compositions containing same and uses thereof Mar 7, 1994 Issued
Array ( [id] => 3557145 [patent_doc_number] => 05543507 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-06 [patent_title] => 'Covalently cross-linked oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 8/205507 [patent_app_country] => US [patent_app_date] => 1994-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37626 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/543/05543507.pdf [firstpage_image] =>[orig_patent_app_number] => 205507 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/205507
Covalently cross-linked oligonucleotides Mar 1, 1994 Issued
Array ( [id] => 3421768 [patent_doc_number] => 05422105 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-06-06 [patent_title] => 'Use of recombinant colony stimulating factor 1' [patent_app_type] => 1 [patent_app_number] => 8/204801 [patent_app_country] => US [patent_app_date] => 1994-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17177 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/422/05422105.pdf [firstpage_image] =>[orig_patent_app_number] => 204801 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/204801
Use of recombinant colony stimulating factor 1 Feb 28, 1994 Issued
Array ( [id] => 3112642 [patent_doc_number] => 05464814 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-11-07 [patent_title] => 'Acellular red blood cell substitute' [patent_app_type] => 1 [patent_app_number] => 8/203505 [patent_app_country] => US [patent_app_date] => 1994-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 14 [patent_no_of_words] => 10115 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 162 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/464/05464814.pdf [firstpage_image] =>[orig_patent_app_number] => 203505 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/203505
Acellular red blood cell substitute Feb 27, 1994 Issued
Array ( [id] => 3699391 [patent_doc_number] => 05646010 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-08 [patent_title] => 'Methods and compositions for expression of competent eukaryotic gene products' [patent_app_type] => 1 [patent_app_number] => 8/197565 [patent_app_country] => US [patent_app_date] => 1994-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 53 [patent_no_of_words] => 19855 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/646/05646010.pdf [firstpage_image] =>[orig_patent_app_number] => 197565 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/197565
Methods and compositions for expression of competent eukaryotic gene products Feb 16, 1994 Issued
Array ( [id] => 3479631 [patent_doc_number] => 05445819 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-08-29 [patent_title] => 'Biological control of mole crickets (Scapteriscus spp.)' [patent_app_type] => 1 [patent_app_number] => 8/199348 [patent_app_country] => US [patent_app_date] => 1994-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6299 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/445/05445819.pdf [firstpage_image] =>[orig_patent_app_number] => 199348 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/199348
Biological control of mole crickets (Scapteriscus spp.) Feb 15, 1994 Issued
Array ( [id] => 3770297 [patent_doc_number] => 05817308 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-06 [patent_title] => 'Tolerogenic fusion proteins of immunoglobulins and methods for inducing and maintaining tolerance' [patent_app_type] => 1 [patent_app_number] => 8/195874 [patent_app_country] => US [patent_app_date] => 1994-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 12627 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/817/05817308.pdf [firstpage_image] =>[orig_patent_app_number] => 195874 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/195874
Tolerogenic fusion proteins of immunoglobulins and methods for inducing and maintaining tolerance Feb 10, 1994 Issued
Array ( [id] => 3516377 [patent_doc_number] => 05512660 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-30 [patent_title] => 'Purified ICAM-2 and fragment thereof' [patent_app_type] => 1 [patent_app_number] => 8/194613 [patent_app_country] => US [patent_app_date] => 1994-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 15679 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/512/05512660.pdf [firstpage_image] =>[orig_patent_app_number] => 194613 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/194613
Purified ICAM-2 and fragment thereof Feb 9, 1994 Issued
Array ( [id] => 3589405 [patent_doc_number] => 05550214 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-27 [patent_title] => 'Isolated antigenic oncogene peptide fragments and uses' [patent_app_type] => 1 [patent_app_number] => 8/195075 [patent_app_country] => US [patent_app_date] => 1994-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 17471 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/550/05550214.pdf [firstpage_image] =>[orig_patent_app_number] => 195075 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/195075
Isolated antigenic oncogene peptide fragments and uses Feb 9, 1994 Issued
Array ( [id] => 3456930 [patent_doc_number] => 05472871 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-12-05 [patent_title] => 'Isolation and characterization of the nematode HER-1 Gene and protein product' [patent_app_type] => 1 [patent_app_number] => 8/194180 [patent_app_country] => US [patent_app_date] => 1994-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 7 [patent_no_of_words] => 18569 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/472/05472871.pdf [firstpage_image] =>[orig_patent_app_number] => 194180 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/194180
Isolation and characterization of the nematode HER-1 Gene and protein product Feb 8, 1994 Issued
08/192808 NEURITE-PROMOTING FACTOR AND PROCESS FOR THE MANUFACTURE THEREOF Feb 7, 1994 Abandoned
08/192274 USES OF GREEN FLUORESCENT PROTEIN Feb 3, 1994 Abandoned
08/183099 METHOD FOR PURIFYING COLONY STIMULATING FACTOR PROTEIN AND SUBSTANTIALLY PURE CSF PROTEIN OBTAINED THEREBY Jan 13, 1994 Abandoned
08/180701 TRANSKARYOTIC IMPLANTATION Jan 12, 1994 Abandoned
08/179873 NOVEL HUMAN MAST CELL-DERIVED POLYPEPTIDES (HMC-DPS), THEIR PRODUCTION AND USES Jan 10, 1994 Abandoned
Menu